QUOTE AND NEWS
StreetInsider.com  Sep 8  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Pluristem+Therapeutics+%28PSTI%29+Reports+Initial+Dosing+of+PLX-PAD+Phase+I+%28UTHR%29/9811922.html for the full story.
Motley Fool  Aug 29  Comment 
United Therapeutics stock is among today's top gainers after it announces a favorable legal ruling regarding its best-selling drug, Remodulin.
StreetInsider.com  Aug 29  Comment 
52-Week High: Digital Ally (Nasdaq: DGLY) $19.55. Digital Ally continuing to see strong gains Friday as on-officer camera speculation heats up. The stock has moved over 360 percent higher since August 18th and closed 36 percent better on...
Benzinga  Aug 29  Comment 
Shares of United Therapeutics (NASDAQ: UTHR) are trading sharply higher on news that patent infringement ruling against competitor Sandoz. The ruling disallows Sandoz to sell the generic version of United Therapeutics hypertension drug...
Market Intelligence Center  Aug 28  Comment 
Option-trade picking algorithms patented by MarketIntelligenceCenter.com found a trading opportunity with United Therapeutics (UTHR) that should provide a 5.40% return in just 51 days. Sell one Oct. '14 call at the $92.50 level for each 100 shares...
SeekingAlpha  Aug 12  Comment 
ByDoctoRx: Background: A year ago, United Therapeutics (NASDAQ:UTHR) came out with a strong quarterly earnings report, and I wrote a bullish article on it titled United Therapeutics - A Low PE, Fast-Growing Biotech Stock. Since then, the stock...
Market Intelligence Center  Jul 31  Comment 
Option-trade picking algorithms patented by MarketIntelligenceCenter.com found a trading opportunity with United Therapeutics (UTHR) that should provide a 4.53% return in just 51 days. Sell one Sep. '14 call at the $92.50 level for each 100 shares...
SeekingAlpha  Jul 29  Comment 
United Therapeutics (NASDAQ:UTHR) Q2 2014 Earnings Call July 29, 2014 9:00 am ET Executives Martine A. Rothblatt - Founder, Chairman and Chief Executive Officer Roger A. Jeffs - President, Chief Operating Officer and Director ...
Market Intelligence Center  Jul 29  Comment 
The patented option trade-picking algorithms behind MarketIntelligenceCenter.com's Artificial Intelligence Center have selected a covered call trade on United Therapeutics (UTHR) that includes 8.15% downside protection. Sell one contract of the...
Market Intelligence Center  Jul 24  Comment 
After closing Wednesday at $93.78, United Therapeutics (UTHR) presents an attractive opportunity to get a 5.02% return in just 58 days, which is an annualized return of 31.58% (for comparison purposes only). To enter this trade, sell one Sep. '14...





You may also be interested in articles related to United Therapeutics (UTHR):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki